Clinical trial
Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive…
NCT00296894 · University Hospital, Ghent, Other · Completed
Key facts
| NCT number | NCT00296894 |
|---|---|
| Title | Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints |
| Official title | TNF-Blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints: Randomized, Double Blind, Placebo-Controlled Cross-Over Study to Evaluate the Efficacy of Adalimumab 40 mg SC Every Other Week in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints |
| Lead sponsor | University Hospital, Ghent, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Erosive Osteo-Arthritis |
| Intervention type | Drug |
| Interventions | Adalimumab (40 mg sc every other week), Placebo |
| Enrollment | 60 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Feb 27, 2006 |
| Last update posted | Feb 9, 2009 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: